Medtronic Boosts FY24 Outlook - Update

RTTNews | Před 454 dny
Medtronic Boosts FY24 Outlook - Update

(RTTNews) - While reporting financial results for the third quarter on Tuesday, medical devices maker Medtronic plc. (MDT) raised its adjusted earnings and organic revenue growth guidance for the full-year 2024, based on third quarter performance.

For fiscal 2023, the company now projects adjusted earnings in a range of $5.19 to $5.21 per share on organic revenue growth of 4.75 to 5.0 percent.

Previously, the company expected adjusted earnings in the range of $5.13 to $5.19 per share on organic revenue growth of 4.75 percent.

On average, 32 analysts polled by Thomson Reuters expect the company to report earnings of $5.16 per share for the quarter. Analysts' estimates typically exclude special items.

"In addition to delivering durable sales growth, we also drove improvements to our margins, as our cost efficiency programs helped to offset the impact of inflation, tax, and currency, contributing to our EPS and cash flow performance in the quarter," said Karen Parkhill, Medtronic chief financial officer.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com

Značky : MDT
read more
Medtronic Files Complaint Against Axonics With US ITC For Two Patent Infringements

Medtronic Files Complaint Against Axonics With US ITC For Two Patent Infringements

Healthcare technology company Medtronic plc (MDT) announced Thursday it filed a complaint with the U.S. International Trade Commission (ITC), along with a parallel action in U.S. District Court for the District of Delaware, to block Axonics, Inc. (AXNX) from improperly importing and selling products that infringe two Medtronic patents related to the MRI compatibility of implantable medical devices.
RTTNews | Před 445 dny
Medtronic Boosts FY23 Adj. EPS Outlook - Update

Medtronic Boosts FY23 Adj. EPS Outlook - Update

While reporting financial results for the third quarter on Tuesday, medical devices maker Medtronic plc. (MDT) provided its revenue growth guidance for the fourth quarter and raised adjusted earnings outlook for the full-year 2023, based on third quarter performance.
RTTNews | Před 818 dny
Medtronic Reiterates FY23 Outlook - Update

Medtronic Reiterates FY23 Outlook - Update

While reporting financial results for the first quarter on Tuesday, medical devices maker Medtronic plc. (MDT) reiterated its adjusted earnings and revenue growth guidance for the full-year 2023.
RTTNews | Před 1000 dny
Eurozone Growth Outlook Downgraded; Disinflation To Proceed More Swiftly: EU

Eurozone Growth Outlook Downgraded; Disinflation To Proceed More Swiftly: EU

Eurozone economic growth outlook was downgraded substantially for 2025 due to the impact of higher trade tariffs and elevated uncertainty and disinflation would proceed more swiftly than anticipated with headline inflation set to hit the 2 percent target by the middle of this year, the European Commission said Monday.
RTTNews | Před 57 minutami